4-chloro-1-methylindoline-2,3-dione
97%
- Product Code: 166856
CAS:
122750-24-7
| Molecular Weight: | 195.605 g./mol | Molecular Formula: | C₉H₆ClNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD14641945 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its reactive functional groups, enabling the formation of complex heterocyclic structures. Also employed in research settings for the design of bioactive molecules with potential antiviral and anti-inflammatory properties. Its structural features make it valuable in structure-activity relationship (SAR) studies to optimize drug candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | ฿24,310.00 |
+
-
|
4-chloro-1-methylindoline-2,3-dione
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its reactive functional groups, enabling the formation of complex heterocyclic structures. Also employed in research settings for the design of bioactive molecules with potential antiviral and anti-inflammatory properties. Its structural features make it valuable in structure-activity relationship (SAR) studies to optimize drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :